These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11315941)

  • 1. Cyclooxygenase 2 inhibition and thrombosis: comment on the article by Crofford et al.
    McMurray R
    Arthritis Rheum; 2001 Apr; 44(4):984. PubMed ID: 11315941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase 2 inhibitors and thrombogenicity production: comment on the article by Crofford et al.
    Sperling R; Braunstein N; Melin J; Reicin A
    Arthritis Rheum; 2001 May; 44(5):1229-30. PubMed ID: 11352260
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases.
    Crofford LJ; Oates JC; McCune WJ; Gupta S; Kaplan MJ; Catella-Lawson F; Morrow JD; McDonagh KT; Schmaier AH
    Arthritis Rheum; 2000 Aug; 43(8):1891-6. PubMed ID: 10943882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coxibs, selective inhibitors of cyclooxygenase-2.
    Killen JP
    N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

  • 6. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J
    Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract]   [Full Text] [Related]  

  • 10. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

  • 11. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Fernandez H; Lesser GT
    JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH
    JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-reactivity and sulfonamide antibiotics.
    Wetstone HJ
    N Engl J Med; 2004 Jan; 350(3):302-3; author reply 302-3. PubMed ID: 14732937
    [No Abstract]   [Full Text] [Related]  

  • 16. COX-1 sparing and COX-2 inhibitory drugs: the renal and hepatic safety and tolerability profiles of celecoxib.
    Whelton A
    Am J Ther; 2000 May; 7(3):151-2. PubMed ID: 11317163
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitor update.
    Bassett K; Wright JM; Puil L; Perry TL; Heran B; Cole B
    Can Fam Physician; 2002 Sep; 48():1455-7, 1458-60. PubMed ID: 12371304
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting of clinical trials of analgesia.
    Katz N
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.